Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Tempest Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −6 vs. Q1 2025
- Shares held
- 944.6K
- −5.04M (−84.2%) vs. Q1 2025
- Total value
- $6.42M
- +$2.00M (+45.4%) vs. Q1 2025
- New holders
- 3
- 1 more added
- Sold out
- 9
- 14 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TPST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.44M |
| Q1 2026 | 22 | $1.29M |
| Q4 2025 | 21 | $2.26M |
| Q3 2025 | 17 | $6.02M |
| Q2 2025 | 18 | $6.42M |
| Q1 2025 | 24 | $4.42M |
| Q4 2024 | 35 | $5.66M |
| Q3 2024 | 28 | $3.94M |
| Q2 2024 | 24 | $4.70M |
| Q1 2024 | 30 | $7.58M |
| Q4 2023 | 32 | $9.88M |
| Q3 2023 | 24 | $1.05M |
| Q2 2023 | 22 | $4.86M |
| Q1 2023 | 17 | $8.72M |
| Q4 2022 | 13 | $3.54M |
| Q3 2022 | 16 | $5.36M |
| Q2 2022 | 16 | $6.67M |
| Q1 2022 | 15 | $7.12M |
| Q4 2021 | 19 | $12.4M |
| Q3 2021 | 22 | $31.8M |
| Q2 2021 | 24 | $20.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Tempest Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 276,587 | $1.88M | 14.47% | +276,587 | New |
| Versant Venture Management, LLC | 269,772 | $1.83M | 2.23% | −3,237,283−92.3% | Reduced |
| Tang Capital Management LLC | 138,962 | $944.9K | 0.05% | +138,962 | New |
| Vanguard Group Inc | 134,608 | $915.3K | 0.00% | −163,269−54.8% | Reduced |
| BlackRock, Inc. | 39,068 | $265.7K | 0.00% | −522,435−93.0% | Reduced |
| Geode Capital Management, LLC | 34,736 | $236.2K | 0.00% | −398,610−92.0% | Reduced |
| FMR LLC | 33,225 | $225.9K | 0.00% | −398,707−92.3% | Reduced |
| UBS Group AG | 11,223 | $76.3K | 0.00% | −312,476−96.5% | Reduced |
| Morgan Stanley | 2,107 | $14.3K | 0.00% | −42,358−95.3% | Reduced |
| Advisor Group Holdings, Inc. | 1,834 | $12.5K | 0.00% | −23,888−92.9% | Reduced |
| National Bank of Canada | 1,538 | $10.4K | 0.00% | −18,462−92.3% | Reduced |
| Federation des caisses Desjardins du Quebec | 292 | $1.99K | 0.00% | −3,508−92.3% | Reduced |
| CIBC Private Wealth Group, LLC | 260 | $1.77K | 0.00% | +127+95.5% | Added |
| Raymond James Financial Inc | 234 | $1.59K | 0.00% | +234 | New |
| SBI Securities Co., Ltd. | 56 | $381 | 0.00% | −711−92.7% | Reduced |
| Bank of America Corp | 33 | $225 | 0.00% | −316−90.5% | Reduced |
| Parallel Advisors, LLC | 18 | $122 | 0.00% | −218−92.4% | Reduced |
| BNP Paribas Arbitrage, SA | 3 | $20 | 0.00% | −45−93.8% | Reduced |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −114,559−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −99,391−100.0% | Sold out |
| Davenport & Co LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −41,492−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −20,422−100.0% | Sold out |
| MayTech Global Investments, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Millstone Evans Group, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −77−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1−100.0% | Sold out |